Posted at 18:54h
in Headache Fact Sheets
The Food and Drug Administration has approved divalproex sodium (Depakote® and Depakote ER) from Abbott Laboratories as a prophylactic medication for migraine headache. However, divalproex sodium is not a new compound. It has been in use since 1983 for treating epilepsy and is also approved as an alternative treatment to lithium for bipolar disorder. Several clinical trials have demonstrated its effectiveness in migraine prevention.